Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003

Author： Lee Yue-Chune  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.9, 2006-01, pp. : 891-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-containment strategies successful in Taiwan

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cost-Containment as Part of Pharmaceutical Policy

By Almarsdóttir Anna   Traulsen Janine  

Pharmacy World and Science, Vol. 27, Iss. 3, 2005-06 ,pp. : 144-148

Springer Publishing Company

Access to resources Recommend Favorite

National health insurance system proposed for the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Drug price cuts have been made a priority for the French government's pharmaceutical cost-containment policy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan

By Hsiao Fei-Yuan   Huang Weng-Foung  

Drug Safety, Vol. 32, Iss. 8, 2009-08 ,pp. : 675-690

Adis International

Access to resources Recommend Favorite